10K Genomics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

10K Genomics General Information

Description

Provider of single-cell immunosequencing and T cell analysis services for research organizations and commercial pharmaceutical companies. The company specializes in developing T cell receptor repertoire sequencing techniques for therapeutics, diagnostics, and treatment monitoring purposes, providing professional and reliable geno-sequencing solutions for major pharmaceutical commercialization.

Contact Information

Website
10kgenomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 409, Building 4, Phase 2, Jukeyuan
  • 333 Guiping Avenue, Caohejing Development Zone
  • Shanghai
  • China
+86 186
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Room 409, Building 4, Phase 2, Jukeyuan
  • 333 Guiping Avenue, Caohejing Development Zone
  • Shanghai
  • China
+86 186

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

10K Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 04-Feb-2021 Completed Startup
2. Early Stage VC (Series A) 29-Dec-2020 Completed Startup
1. Early Stage VC 22-Mar-2019 $745K $745K Completed Startup
To view 10K Genomics’s complete valuation and funding history, request access »

10K Genomics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

10K Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3219822-A1 Composition and method for analyzing target molecule from sample Pending 21-May-2021
EP-4343002-A1 Composition and method for analyzing target molecule from sample Pending 21-May-2021
US-20240229106-A1 Composition and method for analyzing target molecule from sample Pending 21-May-2021 C12Q1/6816

10K Genomics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDBI Partners Venture Capital Minority
Northern Light Venture Capital Venture Capital Minority
Unifortune Investment Asset Manager Minority
Empower Investment (China) Venture Capital Minority
To view 10K Genomics’s complete investors history, request access »

Ready to get started?

Request a free trial

10K Genomics FAQs

  • When was 10K Genomics founded?

    10K Genomics was founded in 2018.

  • Where is 10K Genomics headquartered?

    10K Genomics is headquartered in Shanghai, China.

  • What industry is 10K Genomics in?

    10K Genomics’s primary industry is Biotechnology.

  • Is 10K Genomics a private or public company?

    10K Genomics is a Private company.

  • What is 10K Genomics’s current revenue?

    The current revenue for 10K Genomics is .

  • How much funding has 10K Genomics raised over time?

    10K Genomics has raised $16M.

  • Who are 10K Genomics’s investors?

    CDBI Partners, Northern Light Venture Capital, Unifortune Investment, and Empower Investment (China) have invested in 10K Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »